首页 > 最新文献

Prostaglandins & other lipid mediators最新文献

英文 中文
Effect of Menaquinone-7 (MK-7) Supplementation on Anthropometric Measurements, Glycemic Indices, and Lipid Profiles: A Systematic Review and Meta-Analysis of Randomized Controlled Trials 补充甲基萘醌-7 (MK-7)对人体测量、血糖指数和脂质谱的影响:随机对照试验的系统评价和荟萃分析
IF 2.5 3区 生物学 Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-03-01 Epub Date: 2025-03-05 DOI: 10.1016/j.prostaglandins.2025.106970
Omid Nikpayam , Ali Jafari , Amirhossein Faghfouri , Mohammadjavad Pasand , Pardis Noura , Marziyeh Najafi , Golbon Sohrab

Background

Menaquinone-7 (MK-7) is a type of vitamin K that has a longer half-life and stays in the body for a more extended period compared to other types of vitamin K. Recently, the effects of this vitamin on body weight, glycemic control, and lipid profiles have garnered much attention. Aim of the review: This systematic review and meta-analysis were performed to evaluate the effects of MK-7 on anthropometric measurements, glycemic indices, and lipid profiles.

Methods

A systematic search via appropriate keywords was conducted in electronic databases including PubMed, Scopus, Web of Science, and Google Scholar up to October 2023 to obtain relevant original articles. The quality of studies was evaluated using the Cochrane Collaboration tool. Six original articles met our criteria and were included in the analysis.

Results

Statistical analysis showed that MK-7 had a desirable effect on inulin (SMD= −0.56; 95 % CI: −0.77, −0.36; P = 0.000, I2 = 84 %, P = 0.000), HbA1c (SMD=-0.32; 95 % CI: −0.55, −0.09; P = 0.007, I2 = 86.8 %, P = 0.000), and homeostatic Model Assessment for Insulin Resistance (HOMA-IR) (SMD= −0.56; 95 % CI: −0.76, −0.35; P = 0.000, I2 = 84.3 %, P = 0.000). Additionally, subgroup analysis revealed negligible effects of MK-7 on total cholesterol (TC), insulin, HbA1c, and HOMA-IR in both genders of patients who received ≤ 90 mg MK-7 for less than 12 weeks. However, MK-7 didn’t have any meaningful effect on other factors.

Conclusion

Based on the findings of the present systematic review and meta-analysis, MK-7 may have beneficial effects on glycemic control and TC, although further highly qualified original research is needed for a consistent conclusion.
背景:与其他类型的维生素K相比,甲基萘醌-7 (MK-7)是一种半衰期更长、在体内停留时间更长的维生素K。最近,这种维生素对体重、血糖控制和脂质谱的影响引起了人们的广泛关注。综述的目的:本系统综述和荟萃分析旨在评估MK-7对人体测量、血糖指数和脂质谱的影响。方法:在PubMed、Scopus、Web of Science、谷歌Scholar等截止到2023年10月的电子数据库中,通过合适的关键词进行系统检索,获取相关原创文章。使用Cochrane协作工具评估研究的质量。六篇符合我们标准的原创文章被纳入分析。结果:经统计分析,MK-7对菊粉有较好的效果(SMD= -0.56;95% ci: -0.77, -0.36;P=0.000, I2= 84%, P=0.000), HbA1c (SMD=-0.32;95% ci: -0.55, -0.09;P=0.007, I2= 86.8%, P=0.000),以及胰岛素抵抗稳态模型评估(HOMA-IR) (SMD= -0.56;95% ci: -0.76, -0.35;P=0.000, i2 = 84.3%, P=0.000)。此外,亚组分析显示,在接受≤90mg MK-7治疗不足12周的男女患者中,MK-7对总胆固醇(TC)、胰岛素、HbA1c和HOMA-IR的影响可以忽略不计。然而,MK-7对其他因素没有显著影响。结论:基于本系统综述和荟萃分析的结果,MK-7可能对血糖控制和TC有有益作用,尽管需要进一步的高质量的原始研究来得出一致的结论。
{"title":"Effect of Menaquinone-7 (MK-7) Supplementation on Anthropometric Measurements, Glycemic Indices, and Lipid Profiles: A Systematic Review and Meta-Analysis of Randomized Controlled Trials","authors":"Omid Nikpayam ,&nbsp;Ali Jafari ,&nbsp;Amirhossein Faghfouri ,&nbsp;Mohammadjavad Pasand ,&nbsp;Pardis Noura ,&nbsp;Marziyeh Najafi ,&nbsp;Golbon Sohrab","doi":"10.1016/j.prostaglandins.2025.106970","DOIUrl":"10.1016/j.prostaglandins.2025.106970","url":null,"abstract":"<div><h3>Background</h3><div>Menaquinone-7 (MK-7) is a type of vitamin K that has a longer half-life and stays in the body for a more extended period compared to other types of vitamin K. Recently, the effects of this vitamin on body weight, glycemic control, and lipid profiles have garnered much attention. <strong>Aim of the review:</strong> This systematic review and meta-analysis were performed to evaluate the effects of MK-7 on anthropometric measurements, glycemic indices, and lipid profiles.</div></div><div><h3>Methods</h3><div>A systematic search via appropriate keywords was conducted in electronic databases including PubMed, Scopus, Web of Science, and Google Scholar up to October 2023 to obtain relevant original articles. The quality of studies was evaluated using the Cochrane Collaboration tool. Six original articles met our criteria and were included in the analysis.</div></div><div><h3>Results</h3><div>Statistical analysis showed that MK-7 had a desirable effect on inulin (SMD= −0.56; 95 % CI: −0.77, −0.36; P = 0.000, I2 = 84 %, P = 0.000), HbA1c (SMD=-0.32; 95 % CI: −0.55, −0.09; P = 0.007, I2 = 86.8 %, P = 0.000), and homeostatic Model Assessment for Insulin Resistance (HOMA-IR) (SMD= −0.56; 95 % CI: −0.76, −0.35; P = 0.000, I2 = 84.3 %, P = 0.000). Additionally, subgroup analysis revealed negligible effects of MK-7 on total cholesterol (TC), insulin, HbA1c, and HOMA-IR in both genders of patients who received ≤ 90 mg MK-7 for less than 12 weeks. However, MK-7 didn’t have any meaningful effect on other factors.</div></div><div><h3>Conclusion</h3><div>Based on the findings of the present systematic review and meta-analysis, MK-7 may have beneficial effects on glycemic control and TC, although further highly qualified original research is needed for a consistent conclusion.</div></div>","PeriodicalId":21161,"journal":{"name":"Prostaglandins & other lipid mediators","volume":"177 ","pages":"Article 106970"},"PeriodicalIF":2.5,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143586586","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aspirin-triggered RvD1 (AT-RvD1) modulates epithelial-mesenchymal transition on bronchial epithelial cells stimulated with cigarette smoke extract 阿司匹林触发的RvD1 (AT-RvD1)调节香烟烟雾提取物刺激支气管上皮细胞的上皮-间质转化
IF 2.5 3区 生物学 Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-03-01 Epub Date: 2025-02-19 DOI: 10.1016/j.prostaglandins.2025.106968
Aline Beatriz Mahler Pereira , Bethânia Alves Gontijo , Sarah Cristina Sato Vaz Tanaka , Fernanda Bernadelli de Vito , Hélio Moraes de Souza , Paulo Roberto da Silva , Alexandre de Paula Rogerio
The epithelial-mesenchymal transition (EMT) plays significant role in airway remodeling during chronic obstructive pulmonary disease (COPD) and lung cancer. Aspirin-triggered resolvin D1 (AT-RvD1) presents anti-inflammatory and pro-resolution effects, via lipoxin A4 receptor/formyl peptide receptor 2 (ALX/FPR2). In addition, AT-RvD1 prevented TGF-β1-induced EMT in lung cancer cells (A549 cells). Here, we extend these results and evaluated the role of AT-RvD1 in cigarette smoke extract (CSE)-induced EMT on bronchial epithelial cells (BEAS-2B). CSE decreased E-cadherin expression, an epithelial marker, and increased ROS and TGF-β1 productions, and expressions of mesenchymal markers (N-cadherin, vimentin, smad2/3 and slug). Furthermore, CSE induced an increase in the ALX/FPR2 receptor expression. AT-RvD1 restored the expression of E-cadherin and reduced the N-cadherin, Vimentin, smad2/3 and ALX/FPR2 expressions as well as ROS and TGF-β1 productions on CSE-stimulated cells. In conclusion, AT-RvD1 has the potential to control epithelial-mesenchymal transition induced by smoking in the normal lung epithelial cells.
上皮-间质转化(EMT)在慢性阻塞性肺疾病(COPD)和肺癌患者气道重塑中起重要作用。阿司匹林触发的溶解蛋白D1 (AT-RvD1)通过脂素A4受体/甲酰基肽受体2 (ALX/FPR2)具有抗炎和促溶解作用。此外,AT-RvD1可阻止TGF-β1诱导的肺癌细胞(A549细胞)EMT。在这里,我们扩展了这些结果,并评估了AT-RvD1在香烟烟雾提取物(CSE)诱导的支气管上皮细胞(BEAS-2B)的EMT中的作用。CSE降低了上皮标志物E-cadherin的表达,增加了ROS和TGF-β1的产生以及间质标志物(N-cadherin、vimentin、smad2/3和slug)的表达。此外,CSE诱导ALX/FPR2受体表达增加。AT-RvD1恢复了cse刺激细胞E-cadherin的表达,降低了N-cadherin、Vimentin、smad2/3和ALX/FPR2的表达以及ROS和TGF-β1的产生。综上所述,AT-RvD1具有控制吸烟诱导的正常肺上皮细胞上皮-间质转化的潜力。
{"title":"Aspirin-triggered RvD1 (AT-RvD1) modulates epithelial-mesenchymal transition on bronchial epithelial cells stimulated with cigarette smoke extract","authors":"Aline Beatriz Mahler Pereira ,&nbsp;Bethânia Alves Gontijo ,&nbsp;Sarah Cristina Sato Vaz Tanaka ,&nbsp;Fernanda Bernadelli de Vito ,&nbsp;Hélio Moraes de Souza ,&nbsp;Paulo Roberto da Silva ,&nbsp;Alexandre de Paula Rogerio","doi":"10.1016/j.prostaglandins.2025.106968","DOIUrl":"10.1016/j.prostaglandins.2025.106968","url":null,"abstract":"<div><div>The epithelial-mesenchymal transition (EMT) plays significant role in airway remodeling during chronic obstructive pulmonary disease (COPD) and lung cancer. Aspirin-triggered resolvin D1 (AT-RvD1) presents anti-inflammatory and pro-resolution effects, via lipoxin A4 receptor/formyl peptide receptor 2 (ALX/FPR2). In addition, AT-RvD1 prevented TGF-β1-induced EMT in lung cancer cells (A549 cells). Here, we extend these results and evaluated the role of AT-RvD1 in cigarette smoke extract (CSE)-induced EMT on bronchial epithelial cells (BEAS-2B). CSE decreased E-cadherin expression, an epithelial marker, and increased ROS and TGF-β1 productions, and expressions of mesenchymal markers (N-cadherin, vimentin, smad2/3 and slug). Furthermore, CSE induced an increase in the ALX/FPR2 receptor expression. AT-RvD1 restored the expression of E-cadherin and reduced the N-cadherin, Vimentin, smad2/3 and ALX/FPR2 expressions as well as ROS and TGF-β1 productions on CSE-stimulated cells. In conclusion, AT-RvD1 has the potential to control epithelial-mesenchymal transition induced by smoking in the normal lung epithelial cells.</div></div>","PeriodicalId":21161,"journal":{"name":"Prostaglandins & other lipid mediators","volume":"177 ","pages":"Article 106968"},"PeriodicalIF":2.5,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143453402","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Beta-sitosterol regulates PTGS1 to inhibit gastric cancer cell proliferation and angiogenesis 谷甾醇调节PTGS1抑制胃癌细胞增殖和血管生成。
IF 2.5 3区 生物学 Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-03-01 Epub Date: 2025-01-24 DOI: 10.1016/j.prostaglandins.2025.106964
Jindao Wang , Minghui Zhou , Qiuli Zhou , Guangyang Sun , Yu Zhang , Feng Tao , Minfeng Ye

Background

Gastric cancer (GC) is the third leading culprit of cancer-related deaths around the world. Beta-sitosterol (BS) is an important phytosterol that has been proven to have anti-proliferative effects on GC and other tumors. However, mechanisms and targets of BS in cancer are rarely explored.

Methods

In this investigation, the targets of BS in the treatment of GC were analyzed by network pharmacology. Molecular docking and cellular thermal shift assay were introduced to validate the binding relationship between BS and PTGS1. The impacts of BS on GC cell viability, half maximal inhibitory concentration, proliferation ability, apoptosis level, and angiogenesis ability were detected by using Cell Counting Kit-8, clone formation assay, flow cytometry, and angiogenesis experiment, respectively. In addition, the expression levels of angiogenic factors (VEGF, FGF, PAI-1) were detected by using western blot.

Results

In this project, through cell experiments, PTGS1 was identified as a protein that directly binds to BS. In vitro cell experiments revealed that BS promoted apoptosis and inhibited GC cell proliferation and angiogenesis. Importantly, treatment with BS attenuated the promoting influence of PTGS1 overexpression on GC cell proliferation and angiogenesis.

Conclusion

This investigation highlighted PTGS1 as the target of BS in GC cells. BS can regulate PTGS1 to inhibit GC cell proliferation and angiogenesis, providing new evidence for the potential use of BS as a therapeutic agent for GC.
背景:胃癌(GC)是全球癌症相关死亡的第三大元凶。谷甾醇(BS)是一种重要的植物甾醇,已被证明对胃癌和其他肿瘤具有抗增殖作用。然而,BS在癌症中的作用机制和靶点却很少被探索。方法:采用网络药理学方法对BS治疗GC的作用靶点进行分析。通过分子对接和细胞热移实验验证了BS与PTGS1的结合关系。通过细胞计数试剂盒-8、克隆形成实验、流式细胞术和血管生成实验分别检测BS对胃癌细胞活力、半最大抑制浓度、增殖能力、凋亡水平和血管生成能力的影响。western blot检测血管生成因子(VEGF、FGF、PAI-1)的表达水平。结果:本项目通过细胞实验,鉴定出PTGS1是一种直接结合BS的蛋白。体外细胞实验显示,BS促进胃癌细胞凋亡,抑制胃癌细胞增殖和血管生成。重要的是,BS治疗减弱了PTGS1过表达对GC细胞增殖和血管生成的促进作用。结论:本研究表明PTGS1是GC细胞BS的靶点。BS可调节PTGS1抑制胃癌细胞增殖和血管生成,为BS作为胃癌治疗剂的潜在应用提供了新的证据。
{"title":"Beta-sitosterol regulates PTGS1 to inhibit gastric cancer cell proliferation and angiogenesis","authors":"Jindao Wang ,&nbsp;Minghui Zhou ,&nbsp;Qiuli Zhou ,&nbsp;Guangyang Sun ,&nbsp;Yu Zhang ,&nbsp;Feng Tao ,&nbsp;Minfeng Ye","doi":"10.1016/j.prostaglandins.2025.106964","DOIUrl":"10.1016/j.prostaglandins.2025.106964","url":null,"abstract":"<div><h3>Background</h3><div>Gastric cancer (GC) is the third leading culprit of cancer-related deaths around the world. Beta-sitosterol (BS) is an important phytosterol that has been proven to have anti-proliferative effects on GC and other tumors. However, mechanisms and targets of BS in cancer are rarely explored.</div></div><div><h3>Methods</h3><div>In this investigation, the targets of BS in the treatment of GC were analyzed by network pharmacology. Molecular docking and cellular thermal shift assay were introduced to validate the binding relationship between BS and PTGS1. The impacts of BS on GC cell viability, half maximal inhibitory concentration, proliferation ability, apoptosis level, and angiogenesis ability were detected by using Cell Counting Kit-8, clone formation assay, flow cytometry, and angiogenesis experiment, respectively. In addition, the expression levels of angiogenic factors (VEGF, FGF, PAI-1) were detected by using western blot.</div></div><div><h3>Results</h3><div>In this project, through cell experiments, PTGS1 was identified as a protein that directly binds to BS. <em>In vitro</em> cell experiments revealed that BS promoted apoptosis and inhibited GC cell proliferation and angiogenesis. Importantly, treatment with BS attenuated the promoting influence of PTGS1 overexpression on GC cell proliferation and angiogenesis.</div></div><div><h3>Conclusion</h3><div>This investigation highlighted PTGS1 as the target of BS in GC cells. BS can regulate PTGS1 to inhibit GC cell proliferation and angiogenesis, providing new evidence for the potential use of BS as a therapeutic agent for GC.</div></div>","PeriodicalId":21161,"journal":{"name":"Prostaglandins & other lipid mediators","volume":"177 ","pages":"Article 106964"},"PeriodicalIF":2.5,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143041091","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The interplay of LDLR, PCSK9, and lncRNA- LASER genes expression in coronary artery disease: Implications for therapeutic interventions 冠状动脉疾病中 LDLR、PCSK9 和 lncRNA- LASER 基因表达的相互作用:对治疗干预的影响。
IF 2.5 3区 生物学 Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-03-01 Epub Date: 2025-02-26 DOI: 10.1016/j.prostaglandins.2025.106969
Tayebe Ghiasvand , Jamshid Karimi , Iraj Khodadadi , Amirhossein Yazdi , Salman Khazaei , Zahra Abedi kichi , Seyed Kianoosh Hosseini

Background and purpose

Coronary artery disease (CAD) is defined as stenosis of coronary arteries due to atherosclerosis. The etiology of atherosclerosis can be attributed to a disruption in lipid metabolism, specifically cholesterol and low-density lipoprotein cholesterol (LDL-C). PCSK9 is an enzyme that controls the metabolism of LDL-C by degrading the low-density lipoprotein receptor (LDLR), which in turn affects the metabolism of LDL-C. A newly discovered Long Non-coding RNA named LASER, which affects the homeostasis of cholesterol, has been identified through the evaluation of bioinformatics. The objective of this study was to assess the levels of gene expression related to cholesterol balance, specifically LDLR, PCSK9, and LASER, in peripheral blood mononuclear cells (PBMCs) of Iranian CAD patients in comparison to controls.

Experimental approach

This case-control study included 49 CAD patients, with 81.63 % receiving statins, compared to 40 control subjects, of whom 40 % received statins. The qRT-PCR was used to analyze the expression levels of LDLR, PCSK9, and LASER in PBMCs. Additionally, the ELISA method was employed to determine the blood concentration of PCSK9.

Findings / results

CAD patients demonstrated a significant reduction in PBMC gene expression levels of LDLR (P < 0.01) and a significant rise in gene expression of PCSK9 and LASER, as well as blood concentration of PCSK9 (P < 0.05) compared to controls. The gene expression of PCSK9 showed a strong positive relationship with LDLR expression in patients (P = 0.0003). Furthermore, a strong correlation was seen between PCSK9 and LASER, as well as LASER and LDLR expression (P < 0.0001) in two groups.

Conclusion and implications

PCSK9 and LASER are potential therapeutic targets for atherosclerosis-related disorders, including CAD. Given that patients receiving statins were twice that of the control subjects, and the effect of statins on the LDLR, PCSK9 and LASER, further research is required to delineate the distinct effects of coronary artery disease conditions and statin usage on the expression of the aforementioned genes.
背景与目的:冠状动脉疾病(CAD)是指由动脉粥样硬化引起的冠状动脉狭窄。动脉粥样硬化的病因可归因于脂质代谢的破坏,特别是胆固醇和低密度脂蛋白胆固醇(LDL-C)。PCSK9是一种通过降解低密度脂蛋白受体(LDLR)来控制LDL-C代谢的酶,LDLR反过来影响LDL-C的代谢。通过生物信息学评价,新发现了一种影响胆固醇稳态的长链非编码RNA LASER。本研究的目的是评估伊朗CAD患者外周血单个核细胞(PBMCs)中与胆固醇平衡相关的基因表达水平,特别是LDLR、PCSK9和LASER。实验方法:本病例对照研究纳入49例CAD患者,其中81.63%接受他汀类药物治疗,对照组40例,其中40%接受他汀类药物治疗。采用qRT-PCR分析pbmc中LDLR、PCSK9和LASER的表达水平。采用ELISA法测定PCSK9血药浓度。结果:与对照组相比,患者LDLR中PBMC基因表达水平显著降低(P < 0.01), PCSK9、LASER基因表达及PCSK9血药浓度显著升高(P < 0.05)。PCSK9基因表达与患者LDLR表达呈显著正相关(P = 0.0003)。在两组中,PCSK9与LASER、LASER与LDLR的表达有较强的相关性(P < 0.0001)。结论和意义:PCSK9和LASER是动脉粥样硬化相关疾病(包括CAD)的潜在治疗靶点。考虑到接受他汀类药物治疗的患者是对照组的两倍,以及他汀类药物对LDLR、PCSK9和LASER的影响,需要进一步的研究来描述冠状动脉疾病状况和他汀类药物使用对上述基因表达的明显影响。
{"title":"The interplay of LDLR, PCSK9, and lncRNA- LASER genes expression in coronary artery disease: Implications for therapeutic interventions","authors":"Tayebe Ghiasvand ,&nbsp;Jamshid Karimi ,&nbsp;Iraj Khodadadi ,&nbsp;Amirhossein Yazdi ,&nbsp;Salman Khazaei ,&nbsp;Zahra Abedi kichi ,&nbsp;Seyed Kianoosh Hosseini","doi":"10.1016/j.prostaglandins.2025.106969","DOIUrl":"10.1016/j.prostaglandins.2025.106969","url":null,"abstract":"<div><h3>Background and purpose</h3><div>Coronary artery disease (CAD) is defined as stenosis of coronary arteries due to atherosclerosis. The etiology of atherosclerosis can be attributed to a disruption in lipid metabolism, specifically cholesterol and low-density lipoprotein cholesterol (LDL-C). PCSK9 is an enzyme that controls the metabolism of LDL-C by degrading the low-density lipoprotein receptor (LDLR), which in turn affects the metabolism of LDL-C. A newly discovered Long Non-coding RNA named <em>LASER</em>, which affects the homeostasis of cholesterol, has been identified through the evaluation of bioinformatics. The objective of this study was to assess the levels of gene expression related to cholesterol balance, specifically <em>LDLR</em>, <em>PCSK9</em>, and <em>LASER</em>, in peripheral blood mononuclear cells (PBMCs) of Iranian CAD patients in comparison to controls.</div></div><div><h3>Experimental approach</h3><div>This case-control study included 49 CAD patients, with 81.63 % receiving statins, compared to 40 control subjects, of whom 40 % received statins. The qRT-PCR was used to analyze the expression levels of <em>LDLR</em>, <em>PCSK9</em>, and <em>LASER</em> in PBMCs. Additionally, the ELISA method was employed to determine the blood concentration of PCSK9.</div></div><div><h3>Findings / results</h3><div>CAD patients demonstrated a significant reduction in PBMC gene expression levels of LDLR (P &lt; 0.01) and a significant rise in gene expression of <em>PCSK9</em> and <em>LASER</em>, as well as blood concentration of PCSK9 (P &lt; 0.05) compared to controls. The gene expression of <em>PCSK9</em> showed a strong positive relationship with <em>LDLR</em> expression in patients (P = 0.0003). Furthermore, a strong correlation was seen between <em>PCSK9</em> and <em>LASER</em>, as well as <em>LASER</em> and <em>LDLR</em> expression (P &lt; 0.0001) in two groups.</div></div><div><h3>Conclusion and implications</h3><div>PCSK9 and LASER are potential therapeutic targets for atherosclerosis-related disorders, including CAD. Given that patients receiving statins were twice that of the control subjects, and the effect of statins on the <em>LDLR</em>, <em>PCSK9</em> and <em>LASER</em>, further research is required to delineate the distinct effects of coronary artery disease conditions and statin usage on the expression of the aforementioned genes.</div></div>","PeriodicalId":21161,"journal":{"name":"Prostaglandins & other lipid mediators","volume":"177 ","pages":"Article 106969"},"PeriodicalIF":2.5,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143531118","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Epoxyeicosatrienoic acids (EETs): A novel class of second messengers of hormonal functional responses 环氧二碳三烯酸(EETs):一类新的激素功能反应第二信使。
IF 2.5 3区 生物学 Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-03-01 Epub Date: 2025-01-30 DOI: 10.1016/j.prostaglandins.2025.106967
Jorge H. Capdevila , John R. Falck , Adeniyi Michael Adebesin
Epoxyeicosatrienoic acids (EETs) are a class of cytochrome P450 (P450) arachidonic acid (AA) metabolites with diverse biological activities including anti-hypertensive, vasodilatory, angiogenic, and anti-inflammatory properties. While their functions as autocrine and paracrine mediators in cardiovascular and renal systems are well established, their mechanism of action and roles in hormonal functional responses are yet to be fully defined. In this review, we highlight extant evidence of their participation in hormonal transmembrane signal transduction leading to the activation of the ERK1/2 or Akt serine/threonine kinases. Based on studies with EGF (Epidermal Growth Factor), VEGF (Vascular Endothelial Growth Factor) and insulin binding to their membrane bound receptors, we propose to include EETs to the inventory of intracellular mediators associated with the functional responses elicited upon selected hormone/receptor interactions.
环氧二碳三烯酸(EETs)是一类细胞色素P450 (P450)花生四烯酸(AA)代谢物,具有抗高血压、血管扩张、血管生成和抗炎等多种生物活性。虽然它们在心血管和肾脏系统中作为自分泌和旁分泌介质的功能已经确立,但它们在激素功能反应中的作用机制和作用尚未完全确定。在这篇综述中,我们强调了它们参与激素跨膜信号转导导致ERK1/2或Akt丝氨酸/苏氨酸激酶激活的现有证据。基于对表皮生长因子(EGF)、血管内皮生长因子(VEGF)和胰岛素与其膜结合受体结合的研究,我们建议将eet纳入与选定激素/受体相互作用引起的功能反应相关的细胞内介质清单中。
{"title":"Epoxyeicosatrienoic acids (EETs): A novel class of second messengers of hormonal functional responses","authors":"Jorge H. Capdevila ,&nbsp;John R. Falck ,&nbsp;Adeniyi Michael Adebesin","doi":"10.1016/j.prostaglandins.2025.106967","DOIUrl":"10.1016/j.prostaglandins.2025.106967","url":null,"abstract":"<div><div>Epoxyeicosatrienoic acids (EETs) are a class of cytochrome P450 (P450) arachidonic acid (AA) metabolites with diverse biological activities including anti-hypertensive, vasodilatory, angiogenic, and anti-inflammatory properties. While their functions as autocrine and paracrine mediators in cardiovascular and renal systems are well established, their mechanism of action and roles in hormonal functional responses are yet to be fully defined. In this review, we highlight extant evidence of their participation in hormonal transmembrane signal transduction leading to the activation of the ERK1/2 or Akt serine/threonine kinases. Based on studies with EGF (Epidermal Growth Factor), VEGF (Vascular Endothelial Growth Factor) and insulin binding to their membrane bound receptors, we propose to include EETs to the inventory of intracellular mediators associated with the functional responses elicited upon selected hormone/receptor interactions.</div></div>","PeriodicalId":21161,"journal":{"name":"Prostaglandins & other lipid mediators","volume":"177 ","pages":"Article 106967"},"PeriodicalIF":2.5,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143075073","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effect of saffron supplementation on liver and kidney function, blood glucose and pressure in patients with diabetes and prediabetes: A grade assessed systematic review and meta-analysis of randomized controlled trials 补充藏红花对糖尿病和前驱糖尿病患者肝肾功能、血糖和血压的影响:随机对照试验的系统评价和荟萃分析。
IF 2.5 3区 生物学 Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-03-01 Epub Date: 2025-01-14 DOI: 10.1016/j.prostaglandins.2025.106949
Jia-Wei Zhang , Qing Zhao , Zhe Li , Qian Liu , Sha-Sha Zang , Sha Liu
Saffron has been traditionally used for various health benefits, but its effects on biomarkers of liver function, kidney function, and blood pressure in diabetes are not well understood. This meta-analysis aims to evaluate the impact of saffron supplementation on systolic blood pressure (SBP), diastolic blood pressure (DBP), fasting blood glucose (FBG), liver enzymes (ALT, AST), and kidney function markers (BUN, creatinine) in patients with diabetes and prediabetes. A comprehensive search was conducted across multiple databases to identify randomized controlled trials (RCTs) assessing saffron/crocin supplementation on glycemic control, hepatic and renal function, and blood pressure regulation in patients with diabetes and prediabetes. Data were extracted and analyzed using random effects model to determine the effect sizes and 95 % confidence intervals (CIs) for each biomarker. The GRADE framework was employed to assess the certainty of the evidence for each outcome. Thirteen studies were included in the meta-analysis. Saffron supplementation significantly reduced SBP (SMD = −0.57, 95 % CI: −0.8 to −0.34, p = 0.036) with the high certainty of evidence, FBG (SMD = −0.57, 95 % CI: −0.93 to −0.22, p = 0.001) with the low certainty of evidence, and AST (SMD = −0.49, 95 % CI: −0.97 to −0.00, p = 0.049) with the low certainty of evidence. Other studied biomarkers were not affected significantly by saffron/crocin supplementation. Saffron/crocin supplementation is effective in decreasing AST, SBP, and FBG levels in patients with diabetes and prediabetes. However, it has no significant effect on ALT, renal function, and DBP. Our observed effect sizes on AST, SBP, and FBG are not clinically important.
传统上,藏红花被用于各种健康益处,但其对糖尿病患者肝功能、肾功能和血压的生物标志物的影响尚不清楚。本荟萃分析旨在评估补充藏红花对糖尿病和前驱糖尿病患者收缩压(SBP)、舒张压(DBP)、空腹血糖(FBG)、肝酶(ALT、AST)和肾功能指标(BUN、肌酐)的影响。在多个数据库中进行了全面的搜索,以确定评估藏红花/藏红花素补充对糖尿病和糖尿病前期患者血糖控制、肝肾功能和血压调节的随机对照试验(rct)。提取数据并使用随机效应模型进行分析,以确定每种生物标志物的效应大小和95%置信区间(ci)。GRADE框架被用来评估每个结果证据的确定性。13项研究被纳入meta分析。藏红花补充显著降低收缩压(SMD = -0.57, 95% CI: -0.8至-0.34,p = 0.036),证据确定性高,FBG (SMD = -0.57, 95% CI: -0.93至-0.22,p = 0.001),证据确定性低,AST (SMD = -0.49, 95% CI: -0.97至-0.00,p = 0.049)。其他研究的生物标志物没有受到藏红花/藏红花素补充的显著影响。在糖尿病和前驱糖尿病患者中,补充藏红花/藏红花素可有效降低AST、SBP和FBG水平。但对ALT、肾功能、舒张压无明显影响。我们观察到的AST、SBP和FBG的效应大小在临床上并不重要。
{"title":"The effect of saffron supplementation on liver and kidney function, blood glucose and pressure in patients with diabetes and prediabetes: A grade assessed systematic review and meta-analysis of randomized controlled trials","authors":"Jia-Wei Zhang ,&nbsp;Qing Zhao ,&nbsp;Zhe Li ,&nbsp;Qian Liu ,&nbsp;Sha-Sha Zang ,&nbsp;Sha Liu","doi":"10.1016/j.prostaglandins.2025.106949","DOIUrl":"10.1016/j.prostaglandins.2025.106949","url":null,"abstract":"<div><div>Saffron has been traditionally used for various health benefits, but its effects on biomarkers of liver function, kidney function, and blood pressure in diabetes are not well understood. This meta-analysis aims to evaluate the impact of saffron supplementation on systolic blood pressure (SBP), diastolic blood pressure (DBP), fasting blood glucose (FBG), liver enzymes (ALT, AST), and kidney function markers (BUN, creatinine) in patients with diabetes and prediabetes. A comprehensive search was conducted across multiple databases to identify randomized controlled trials (RCTs) assessing saffron/crocin supplementation on glycemic control, hepatic and renal function, and blood pressure regulation in patients with diabetes and prediabetes. Data were extracted and analyzed using random effects model to determine the effect sizes and 95 % confidence intervals (CIs) for each biomarker. The GRADE framework was employed to assess the certainty of the evidence for each outcome. Thirteen studies were included in the meta-analysis. Saffron supplementation significantly reduced SBP (SMD = −0.57, 95 % CI: −0.8 to −0.34, p = 0.036) with the high certainty of evidence, FBG (SMD = −0.57, 95 % CI: −0.93 to −0.22, p = 0.001) with the low certainty of evidence, and AST (SMD = −0.49, 95 % CI: −0.97 to −0.00, p = 0.049) with the low certainty of evidence. Other studied biomarkers were not affected significantly by saffron/crocin supplementation. Saffron/crocin supplementation is effective in decreasing AST, SBP, and FBG levels in patients with diabetes and prediabetes. However, it has no significant effect on ALT, renal function, and DBP. Our observed effect sizes on AST, SBP, and FBG are not clinically important.</div></div>","PeriodicalId":21161,"journal":{"name":"Prostaglandins & other lipid mediators","volume":"177 ","pages":"Article 106949"},"PeriodicalIF":2.5,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143010773","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Involvement of COX inhibitor and arachidonic acid in manipulating obesity and obesity-induced bone resorption markers in obese mice COX抑制剂和花生四烯酸参与控制肥胖小鼠的肥胖和肥胖诱导的骨吸收标志物
IF 2.5 3区 生物学 Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-03-01 Epub Date: 2025-03-11 DOI: 10.1016/j.prostaglandins.2025.106971
Rahima Begum, Sourav Roy, Md. Abdur Rahman Ripon, Mohammad Tohidul Amin, Mohammad Salim Hossain
Obesity and bone-loss have remained a focus of research. Obesity stimulates adipose tissue expansion and adipocyte hypertrophy, resulting in chronic low-grade inflammation in the adipocytes. This enlarged adipocyte secretes a variety of pro-inflammatory chemicals. Because of their endocrine signaling, these substances indirectly promote osteoclast activity and bone-loss. However, the role of COX-2 signaling in obesity-induced bone resorption gene expression has yet to be investigated. Thus, we conducted this study in the context of obesity, employing a high-fat diet-induced obese mouse model. Obese mice treated with a selective and non-selective COX-2 inhibitor (celecoxib and aspirin), significantly (p < 0.05) reduced adipogenic markers such as body and fat weight, serum lipids, mRNA expression of pro-inflammatory markers (COX-2, TNF-α, IL-6, and MCP-1) in adipose tissue and bone resorption markers (OPG, RANKL, Cathepsin K, and MMP-9) in tibia bone tissue. In addition, arachidonic acid (AA) supplementation significantly (p < 0.5) increased the expression of obesity-induced inflammatory cytokines in the tibia bone marrow via the COX-2-derived PGE2 signaling pathway, hence increase the osteoclastogenesis. These findings suggested that inhibiting the COX-2 signaling pathway could reduce obesity and inflammatory bone resorption. Although both the selective and non-selective COX inhibitors had similar effects, selective COX-2 was more effective in these events, indicating that COX-2 plays a critical role in obesity-associated inflammatory bone resorption.
肥胖和骨质流失一直是研究的焦点。肥胖刺激脂肪组织扩张和脂肪细胞肥大,导致脂肪细胞慢性低度炎症。增大的脂肪细胞分泌多种促炎化学物质。由于其内分泌信号,这些物质间接促进破骨细胞活动和骨质流失。然而,COX-2信号在肥胖诱导的骨吸收基因表达中的作用尚未被研究。因此,我们在肥胖的背景下进行了这项研究,采用高脂肪饮食诱导的肥胖小鼠模型。用选择性和非选择性COX-2抑制剂(塞来昔布和阿司匹林)治疗的肥胖小鼠,显著(p <; 0.05)降低了脂肪生成标志物,如体重和脂肪重、血清脂质、脂肪组织中促炎标志物(COX-2、TNF-α、IL-6和MCP-1)的mRNA表达以及胫骨骨组织中骨吸收标志物(OPG、RANKL、Cathepsin K和MMP-9)。此外,花生四烯酸(AA)的补充显著(p <; 0.5)通过cox -2来源的PGE2信号通路增加了肥胖诱导的炎症细胞因子在胫骨骨髓中的表达,从而增加了破骨细胞的发生。这些发现表明,抑制COX-2信号通路可以减少肥胖和炎症性骨吸收。尽管选择性和非选择性COX抑制剂具有相似的作用,但选择性COX-2在这些事件中更有效,这表明COX-2在肥胖相关的炎症性骨吸收中起关键作用。
{"title":"Involvement of COX inhibitor and arachidonic acid in manipulating obesity and obesity-induced bone resorption markers in obese mice","authors":"Rahima Begum,&nbsp;Sourav Roy,&nbsp;Md. Abdur Rahman Ripon,&nbsp;Mohammad Tohidul Amin,&nbsp;Mohammad Salim Hossain","doi":"10.1016/j.prostaglandins.2025.106971","DOIUrl":"10.1016/j.prostaglandins.2025.106971","url":null,"abstract":"<div><div>Obesity and bone-loss have remained a focus of research. Obesity stimulates adipose tissue expansion and adipocyte hypertrophy, resulting in chronic low-grade inflammation in the adipocytes. This enlarged adipocyte secretes a variety of pro-inflammatory chemicals. Because of their endocrine signaling, these substances indirectly promote osteoclast activity and bone-loss. However, the role of COX-2 signaling in obesity-induced bone resorption gene expression has yet to be investigated. Thus, we conducted this study in the context of obesity, employing a high-fat diet-induced obese mouse model. Obese mice treated with a selective and non-selective COX-2 inhibitor (celecoxib and aspirin), significantly (p &lt; 0.05) reduced adipogenic markers such as body and fat weight, serum lipids, mRNA expression of pro-inflammatory markers (COX-2, TNF-α, IL-6, and MCP-1) in adipose tissue and bone resorption markers (OPG, RANKL, Cathepsin K, and MMP-9) in tibia bone tissue. In addition, arachidonic acid (AA) supplementation significantly (p &lt; 0.5) increased the expression of obesity-induced inflammatory cytokines in the tibia bone marrow via the COX-2-derived PGE<sub>2</sub> signaling pathway, hence increase the osteoclastogenesis. These findings suggested that inhibiting the COX-2 signaling pathway could reduce obesity and inflammatory bone resorption. Although both the selective and non-selective COX inhibitors had similar effects, selective COX-2 was more effective in these events, indicating that COX-2 plays a critical role in obesity-associated inflammatory bone resorption.</div></div>","PeriodicalId":21161,"journal":{"name":"Prostaglandins & other lipid mediators","volume":"177 ","pages":"Article 106971"},"PeriodicalIF":2.5,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143611011","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of curcumin on lipid mediators, glycemic index, and oxidative stress and inflammation biomarkers in polycystic ovary syndrome: Future directions and current knowledge – A systematic review 姜黄素对多囊卵巢综合征中脂质介质、血糖指数、氧化应激和炎症生物标志物的影响:未来方向和现有知识的系统回顾
IF 2.5 3区 生物学 Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-03-01 Epub Date: 2025-01-13 DOI: 10.1016/j.prostaglandins.2024.106947
Hiba Muwafaq Saleem , Hussein Riyadh Abdul Kareem Al-Hetty , Abdulrahman T. Ahmed , Muthanna M. Awad , Mohammed Qais Al-Ani , Mustafa Nuhad Al-Darraji , Dina Akeel Salman , Loay H. Ali
Polycystic ovary syndrome (PCOS) is one of the most common and important polygenic endocrine disorders among women of reproductive-aged. Current treatments are mostly used only to control the signs and symptoms of the disease, while not being able to completely prevent complications. Curcumin is one of the active compounds in turmeric, which is commonly used for a wide range of metabolic and inflammatory diseases. Therefore, this systematic review was performed to evaluate the effect of curcumin supplementation on PCOS. The current systematic review was performed according to the guidelines of the 2015 PRISMA (Preferred Reporting Items for Systematic Review and Meta-Analysis) statements. We searched ProQuest, PubMed, Google Scholar electronic, Scopus, and Cochrane, Embase, and Science Direct databases and on articles published up until November 2024. All of the animal studies (seven studies) and clinical trials (five studies) included in this systematic review that assessed the effect of curcumin on, reproductive hormones and metabolic risk markers in PCOS were published in English-language journals. Most studies supported the beneficial effects of curcumin on folliculogenesis, ovarian histomorphology, and luteinization processes. The effects of curcumin on decreasing the levels of luteinizing insulin resistance luteinizing hormone (LH), Follicle-stimulating hormone (FSH)and testosterone, were also reported. Curcumin also improved dyslipidemia, but no significant effect on weight loss has been reported. It is suggested that the effect of curcumin in PCOS is more related to the antioxidant and anti-inflammatory properties of curcumin than to the effects of weight loss. Therefore, this study provides evidence that curcumin can be considered an effective factor in reducing the complications of PCOS. However, due to the low number of human studies in this field, further clinical trials are warranted to verify these outcomes.
多囊卵巢综合征(PCOS)是育龄妇女最常见、最重要的多基因内分泌疾病之一。目前的治疗大多只用于控制疾病的体征和症状,而不能完全预防并发症。姜黄素是姜黄中的活性化合物之一,常用于多种代谢性和炎症性疾病。因此,本系统综述旨在评价姜黄素补充剂对PCOS的影响。目前的系统评价是根据2015年PRISMA(系统评价和荟萃分析首选报告项目)声明的指南进行的。我们检索了ProQuest、PubMed、谷歌Scholar electronic、Scopus、Cochrane、Embase和Science Direct数据库,以及截止到2024年11月发表的文章。本系统综述中评估姜黄素对多囊卵巢综合征生殖激素和代谢风险标志物影响的所有动物研究(7项研究)和临床试验(5项研究)均发表在英语期刊上。大多数研究支持姜黄素对卵泡形成、卵巢组织形态学和黄体生成过程的有益作用。姜黄素对降低促黄体生成素(LH)、促卵泡激素(FSH)和睾酮水平的影响也有报道。姜黄素也能改善血脂异常,但对减肥没有显著影响。提示姜黄素对多囊卵巢综合征的治疗作用更多地与姜黄素的抗氧化和抗炎作用有关,而不是与减肥作用有关。因此,本研究为姜黄素可被认为是减少PCOS并发症的有效因素提供了证据。然而,由于该领域的人体研究数量较少,需要进一步的临床试验来验证这些结果。
{"title":"Effect of curcumin on lipid mediators, glycemic index, and oxidative stress and inflammation biomarkers in polycystic ovary syndrome: Future directions and current knowledge – A systematic review","authors":"Hiba Muwafaq Saleem ,&nbsp;Hussein Riyadh Abdul Kareem Al-Hetty ,&nbsp;Abdulrahman T. Ahmed ,&nbsp;Muthanna M. Awad ,&nbsp;Mohammed Qais Al-Ani ,&nbsp;Mustafa Nuhad Al-Darraji ,&nbsp;Dina Akeel Salman ,&nbsp;Loay H. Ali","doi":"10.1016/j.prostaglandins.2024.106947","DOIUrl":"10.1016/j.prostaglandins.2024.106947","url":null,"abstract":"<div><div>Polycystic ovary syndrome (PCOS) is one of the most common and important polygenic endocrine disorders among women of reproductive-aged. Current treatments are mostly used only to control the signs and symptoms of the disease, while not being able to completely prevent complications. Curcumin is one of the active compounds in turmeric, which is commonly used for a wide range of metabolic and inflammatory diseases. Therefore, this systematic review was performed to evaluate the effect of curcumin supplementation on PCOS. The current systematic review was performed according to the guidelines of the 2015 PRISMA (Preferred Reporting Items for Systematic Review and Meta-Analysis) statements. We searched ProQuest, PubMed, Google Scholar electronic, Scopus, and Cochrane, Embase, and Science Direct databases and on articles published up until November 2024. All of the animal studies (seven studies) and clinical trials (five studies) included in this systematic review that assessed the effect of curcumin on, reproductive hormones and metabolic risk markers in PCOS were published in English-language journals. Most studies supported the beneficial effects of curcumin on folliculogenesis, ovarian histomorphology, and luteinization processes. The effects of curcumin on decreasing the levels of luteinizing insulin resistance luteinizing hormone (LH), Follicle-stimulating hormone (FSH)and testosterone, were also reported. Curcumin also improved dyslipidemia, but no significant effect on weight loss has been reported. It is suggested that the effect of curcumin in PCOS is more related to the antioxidant and anti-inflammatory properties of curcumin than to the effects of weight loss. Therefore, this study provides evidence that curcumin can be considered an effective factor in reducing the complications of PCOS. However, due to the low number of human studies in this field, further clinical trials are warranted to verify these outcomes.</div></div>","PeriodicalId":21161,"journal":{"name":"Prostaglandins & other lipid mediators","volume":"177 ","pages":"Article 106947"},"PeriodicalIF":2.5,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143010772","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Changes in the serum phospholipid profile of neuroborreliosis patients, foresters, and patients subjected to long-term therapy according to ILADS methods 根据ILADS方法,神经螺旋体病患者、林业人员和接受长期治疗的患者血清磷脂谱的变化。
IF 2.5 3区 生物学 Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-03-01 Epub Date: 2025-02-03 DOI: 10.1016/j.prostaglandins.2025.106966
Wojciech Łuczaj , Anna Moniuszko-Malinowska , Monika Groth , Elżbieta Skrzydlewska
The aim of the study was the assessment of changes in the serum phospholipid profile patients with Lyme neuroborreliosis (NB), asymptomatic people after frequent tick bites and patients after long-term multidrug therapy against B.burgdorferi. LC-QTOF-MS/MS platform was used to identify changes in serum phospholipid profile of 37 persons. The results demonstrate differences PL profile among patients with Lyme borreliosis (LB), people frequently exposed to tick bites and patients treated with long-term multidrug therapy compared to healthy subjects. Significant differences in SM, LPC, PI, and PC content of NB patients discriminate this group of patients from the other groups, have potential diagnostic value, and can be used for the development of more effective diagnostic tools. The finding that the phospholipid profile of foresters is similar to healthy people, suggests the existence of adaptive mechanisms that are currently difficult to explain but are interesting from the perspective of future research.
本研究的目的是评估莱姆病神经螺旋体病(NB)患者、频繁蜱叮咬后无症状人群和长期多药治疗伯氏疏螺旋体患者血清磷脂谱的变化。采用LC-QTOF-MS/MS平台对37人血清磷脂谱的变化进行了分析。结果表明,莱姆病borreliosis (LB)患者、经常接触蜱虫叮咬的人以及长期接受多种药物治疗的患者的PL谱与健康受试者相比存在差异。NB患者的SM、LPC、PI、PC含量存在显著差异,可将本组患者与其他组区分开来,具有潜在的诊断价值,可用于开发更有效的诊断工具。林农的磷脂谱与健康人相似的发现表明,目前难以解释的适应性机制的存在,但从未来研究的角度来看是有趣的。
{"title":"Changes in the serum phospholipid profile of neuroborreliosis patients, foresters, and patients subjected to long-term therapy according to ILADS methods","authors":"Wojciech Łuczaj ,&nbsp;Anna Moniuszko-Malinowska ,&nbsp;Monika Groth ,&nbsp;Elżbieta Skrzydlewska","doi":"10.1016/j.prostaglandins.2025.106966","DOIUrl":"10.1016/j.prostaglandins.2025.106966","url":null,"abstract":"<div><div>The aim of the study was the assessment of changes in the serum phospholipid profile patients with Lyme neuroborreliosis (NB), asymptomatic people after frequent tick bites and patients after long-term multidrug therapy against <em>B.burgdorferi</em>. LC-QTOF-MS/MS platform was used to identify changes in serum phospholipid profile of 37 persons. The results demonstrate differences PL profile among patients with Lyme borreliosis (LB), people frequently exposed to tick bites and patients treated with long-term multidrug therapy compared to healthy subjects. Significant differences in SM, LPC, PI, and PC content of NB patients discriminate this group of patients from the other groups, have potential diagnostic value, and can be used for the development of more effective diagnostic tools. The finding that the phospholipid profile of foresters is similar to healthy people, suggests the existence of adaptive mechanisms that are currently difficult to explain but are interesting from the perspective of future research.</div></div>","PeriodicalId":21161,"journal":{"name":"Prostaglandins & other lipid mediators","volume":"177 ","pages":"Article 106966"},"PeriodicalIF":2.5,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143255281","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Protective role of Yougui Yin in experimental knee osteoarthritis: From the perspective of macrophage polarization 从巨噬细胞极化的角度看养阴清对实验性膝骨关节炎的保护作用
IF 2.5 3区 生物学 Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-01-01 Epub Date: 2024-12-12 DOI: 10.1016/j.prostaglandins.2024.106940
Zhongqing Wu , Kanna Xu , Minchang Chen , Shihao Wang , Yong Ma
Knee osteoarthritis (KOA) refers to a prevalent musculoskeletal disorder, frequently complicated by substantial pain and physical disability. Yougui Yin (YGY) is a classic Chinese herbal mixture which has demonstrated potential in treating KOA. Considering that, its cryptic mechanism warrants to be deciphered, which is the subject of our present research. In vivo, H&E staining, Alcian blue staining and Masson staining assessed the histomorphology. Commercial kits and ELISA evaluated oxidative stress markers. ELISA also assayed serum inflammatory cytokines. TUNEL staining appraised apoptosis. Western blotting examined cartilage matrix degradation, apoptotic and NLRP3 inflammasome proteins. Immunofluorescence assay estimated macrophage polarization. In vitro, ELISA assayed oxidative stress markers and inflammatory cytokines. Immunofluorescence and flow cytometry assay estimated macrophage polarization. MTT and flow cytometry assays severally measured cell viability and apoptosis. DCFH-DA probe detected ROS formation. RT-qPCR and Western blotting examined chondrocyte markers, apoptotic and pyroptotic genes. YGY significantly eased the histomorphological damage, apoptosis and pyroptosis in the cartilage tissues of KOA mice. Besides, YGY exerted anti-oxidant and anti-inflammatory activities and drove M1-to-M2 polarization of macrophages both in vitro and in vivo. Further, the co-culture of macrophages treated by LPS and serum containing YGY improved the viability, eliminated the apoptosis, pyroptosis, inflammation, oxidative stress and cartilage degradation in TNF-α-exposed chondrocytes co-cultured with LPS-intervened macrophages. Overall, YGY might mediate macrophage polarization to impede the advancement of KOA.
膝关节骨性关节炎(KOA)是一种常见的肌肉骨骼疾病,常伴有剧烈疼痛和身体残疾。Yougui Yin(YGY)是一种经典的中药混合物,在治疗膝骨关节炎方面具有潜力。考虑到这一点,我们有必要破译其神秘的机制,这也是我们目前研究的主题。在体内,H&E 染色、Alcian 蓝染色和 Masson 染色评估组织形态学。商用试剂盒和酶联免疫吸附法评估氧化应激标记物。ELISA 还检测了血清中的炎性细胞因子。TUNEL染色评估细胞凋亡。西方印迹法检测软骨基质降解、凋亡和 NLRP3 炎性体蛋白。免疫荧光检测评估了巨噬细胞的极化。在体外,酶联免疫吸附试验检测了氧化应激标记物和炎症细胞因子。免疫荧光和流式细胞仪检测巨噬细胞极化。MTT 和流式细胞术检测分别测定了细胞活力和凋亡。DCFH-DA 探针检测了 ROS 的形成。RT-qPCR 和 Western 印迹检测了软骨细胞标记物、凋亡和热解基因。结果表明,YGY能明显缓解KOA小鼠软骨组织的组织形态学损伤、凋亡和裂解。此外,YGY 还具有抗氧化和抗炎活性,并能在体外和体内促进巨噬细胞的 M1-M2 极化。此外,经 LPS 处理的巨噬细胞与含 YGY 的血清共培养后,TNF-α 暴露的软骨细胞与经 LPS 干预的巨噬细胞共培养后,其存活率提高,凋亡、热噬、炎症、氧化应激和软骨降解均得以消除。总之,YGY 可能会介导巨噬细胞极化,从而阻碍 KOA 的发展。
{"title":"Protective role of Yougui Yin in experimental knee osteoarthritis: From the perspective of macrophage polarization","authors":"Zhongqing Wu ,&nbsp;Kanna Xu ,&nbsp;Minchang Chen ,&nbsp;Shihao Wang ,&nbsp;Yong Ma","doi":"10.1016/j.prostaglandins.2024.106940","DOIUrl":"10.1016/j.prostaglandins.2024.106940","url":null,"abstract":"<div><div>Knee osteoarthritis (KOA) refers to a prevalent musculoskeletal disorder, frequently complicated by substantial pain and physical disability. Yougui Yin (YGY) is a classic Chinese herbal mixture which has demonstrated potential in treating KOA. Considering that, its cryptic mechanism warrants to be deciphered, which is the subject of our present research. In vivo, H&amp;E staining, Alcian blue staining and Masson staining assessed the histomorphology. Commercial kits and ELISA evaluated oxidative stress markers. ELISA also assayed serum inflammatory cytokines. TUNEL staining appraised apoptosis. Western blotting examined cartilage matrix degradation, apoptotic and NLRP3 inflammasome proteins. Immunofluorescence assay estimated macrophage polarization. In vitro, ELISA assayed oxidative stress markers and inflammatory cytokines. Immunofluorescence and flow cytometry assay estimated macrophage polarization. MTT and flow cytometry assays severally measured cell viability and apoptosis. DCFH-DA probe detected ROS formation. RT-qPCR and Western blotting examined chondrocyte markers, apoptotic and pyroptotic genes. YGY significantly eased the histomorphological damage, apoptosis and pyroptosis in the cartilage tissues of KOA mice. Besides, YGY exerted anti-oxidant and anti-inflammatory activities and drove M1-to-M2 polarization of macrophages both in vitro and in vivo. Further, the co-culture of macrophages treated by LPS and serum containing YGY improved the viability, eliminated the apoptosis, pyroptosis, inflammation, oxidative stress and cartilage degradation in TNF-α-exposed chondrocytes co-cultured with LPS-intervened macrophages. Overall, YGY might mediate macrophage polarization to impede the advancement of KOA.</div></div>","PeriodicalId":21161,"journal":{"name":"Prostaglandins & other lipid mediators","volume":"176 ","pages":"Article 106940"},"PeriodicalIF":2.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142824476","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Prostaglandins & other lipid mediators
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1